List

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until April, 2020.

  1. Synthetic antibodies for monitoring modified RNAs

    SBC: ROCKLAND IMMUNOCHEMICALS, INC.            Topic: NIDA

    DESCRIPTION (provided by applicant): Post-transcriptional RNA modification plays an important role in biological processes. For example, adenosines to nosiness or A-to-I editing are most abundant in the central nervous system (CNS) and essential for normalCNS development. Presently, the available reagents for detection, quantitation, or immunoprecipitation of modified RNA are extremely limited. Ro ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Integrating optical coherence tomography with laryngeal high-speed videoendoscopy

    SBC: Physical Sciences Inc.            Topic: NIDCD

    DESCRIPTION (provided by applicant): There is a growing clinical need for improving the assessment of vocal fold tissue properties in vivo, especially dynamic properties measured during human voice production. To address this need, Physical Sciences Inc. (PSI), in collaboration with MGH Voice Center, will develop a clinically-viable imaging system that will integrate optical coherence tomography ( ...

    SBIR Phase I 2014 Department of Health and Human Services
  3. Functional otoscopy for non-invasive diagnosis of middle ear pathologies

    SBC: Physical Sciences Inc.            Topic: NIDCD

    DESCRIPTION (provided by applicant): There is a growing clinical need for improving the non-invasive diagnostic capabilities of middle ear pathologies in vivo. To address this need, Physical Sciences Inc. (PSI), in collaboration with the Eaton Peabody Labat the Massachusetts Eye and Ear Infirmary (MEEI), will develop a clinically viable otoscopic imaging system that will employ phase sensitive opt ...

    SBIR Phase I 2014 Department of Health and Human Services
  4. Customized nanotechnology based treatment of Oral Cancer

    SBC: PRIVO TECHNOLOGIES, LLC            Topic: NIDCR

    DESCRIPTION (provided by applicant): According to the Oral Cancer (OC) Foundation, oral and pharyngeal cancer will cause 8,000 deaths this year, killing roughly one person per hour. Currently, cisplatin (CIS) is at the forefront of platinum- based chemotherapeutics for treating OC. However, its efficacy is often hindered by its significant systemic toxicity as a result of traditional bolus systemi ...

    SBIR Phase I 2014 Department of Health and Human Services
  5. Development of Salivary Analyte Stabilizers

    SBC: SALIMETRICS, LLC            Topic: NIDCR

    DESCRIPTION (provided by applicant): Saliva, like blood, contains a wealth of hormones, proteins and nucleic acid molecules that reflect physiological status; however, unlike other bodily fluids such as blood, salivary diagnostics offer an easy, inexpensive, safe, and non-invasive approach for biomarker identification, disease detection and drug monitoring, and have a high potential to revolutioni ...

    SBIR Phase I 2014 Department of Health and Human Services
  6. Salivary oxytocin as a biomarker for autism spectrum disorder

    SBC: SALIMETRICS, LLC            Topic: NIDCR

    DESCRIPTION (provided by applicant): Oxytocin is a secreted, peptide hormone that is involved in modulating a wide range of central and peripheral physiological responses. Most notably, it has been implicated in social behaviors, including parental behavior, the formation of social bonds, and the management of stressful experiences. Given the increased interest and important role of this peptide i ...

    SBIR Phase I 2014 Department of Health and Human Services
  7. Parents.Cope: A tool for Parents of Adolescents with T1DM

    SBC: New England Research Institutes, Inc.            Topic: NIDDK

    PROJECT SUMMARY/ABSTRACT Type 1 diabetes (T1DM) is the most common chronic illness in children, affecting 1 in 400 with evidence that its prevalence is increasing worldwide. Parents of children with T1DM are responsible for a labor-intensive and complicated daily regimen that has been described as an overwhelming experience, requiring constant vigilance. The prevalence of anxiety symptoms for par ...

    SBIR Phase I 2014 Department of Health and Human Services
  8. A novel, orally available small molecule AMPK activator as a treatment for non al

    SBC: MERCURY THERAPEUTICS. INC.            Topic: NIDDK

    DESCRIPTION (provided by applicant): No specific therapies exist for nonalcoholic steatohepatitis (NASH), which affects 2-5% of Americans. The long term goal of this project is to develop DB0930-007-a novel, highly specific, orally available small moleculeactivator of 5'-AMP-activated kinase (AMPK)-as an innovative treatment for NASH. Preliminary data indicate that administration of DB0930-00 ...

    SBIR Phase I 2014 Department of Health and Human Services
  9. Pharmacological evaluation of MLR-1023: Studies to confirm efficacy, establish a

    SBC: Melior Discovery, Inc.            Topic: NIDDK

    DESCRIPTION (provided by applicant): The goals of this project are to develop a biomarker for MLR-1023 in order to validate Lyn kinase as a molecular target for treatment of Type II diabetes (T2D) and use the biomarker to understand the pharmacokinetic/pharmacodynamic (PK/PD) disconnect in order to optimize a dosing regimen in clinical trials. These goals will be accomplished by showing MLR-1023 t ...

    SBIR Phase I 2014 Department of Health and Human Services
  10. Protection Against Chemotherapy-Induced Gastrointestinal Mucositis by a Sphingosi

    SBC: Apogee Biotechnology Corporation            Topic: NIDDK

    DESCRIPTION (provided by applicant): Mucositis caused by excessive inflammation within the gastrointestinal tract is a costly and debilitating toxicity commonly experienced by patients receiving radiation and/or drugs as cancer therapy. Sphingolipids are being increasingly recognized as key mediators of inflammation, and are known to be essential for signaling by pro-inflammatory cytokines such as ...

    SBIR Phase I 2014 Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government